SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-011067
Filing Date
2019-04-09
Accepted
2019-04-09 08:01:03
Documents
4
Period of Report
2019-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K phas-8k_20190409.htm 8-K 37465
2 EX-10.1 phas-ex101_12.htm EX-10.1 32707
3 EX-99.1 phas-ex991_7.htm EX-99.1 14532
4 GRAPHIC g2akg1qvuqod000001.jpg GRAPHIC 9524
  Complete submission text file 0001564590-19-011067.txt   99320
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38697 | Film No.: 19738491
SIC: 2834 Pharmaceutical Preparations